These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16320693)

  • 1. [A pH-dependent mechanism of energy transformation in joint fluid cells in osteoarthrosis of the knee joint and benefits of chondroitinsulfate].
    Shishkin VI; Kudriavtseva GV; Riabkov AB
    Ter Arkh; 2005; 77(10):79-82. PubMed ID: 16320693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term effects of structum administration (according to data from multicenter trial)].
    Alekseeva LI; Arkhangel'skaia GS; Davydova AF; Karmil'tseva EA; Kogan KM; Mazurov VI; Rebrov AP; Riabitseva OF; Shemerovskaia TG; Iakushin SS
    Ter Arkh; 2003; 75(9):82-6. PubMed ID: 14582441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacoeconomic aspects of use of structum in osteoarthrosis].
    Alekseeva LI; Mednikov BL; Piiavskiĭ SA; Nasonova VA; Soldatov DG
    Ter Arkh; 2001; 73(11):90-2. PubMed ID: 11806219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of the multicenter clinical trial of structum preparation in Russia].
    Nasonova VA; Alekseeva LI; Arkhangel'skaia GS; Davydova AF; Karmil'tseva EA; Kogan KM; Mazurov VI; Rebrov AP; Riabitseva OF; Shemerovskaia TG; Shmidt EI; Iakushin SS; Soldatov DG
    Ter Arkh; 2001; 73(11):84-7. PubMed ID: 11806217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee.
    Bagga H; Burkhardt D; Sambrook P; March L
    J Rheumatol; 2006 May; 33(5):946-50. PubMed ID: 16652425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional indices in assessment of gonarthrosis treatment efficacy with structum and chondrolon].
    Maĭko OIu; Bagirova GG
    Ter Arkh; 2006; 78(6):47-52. PubMed ID: 16881363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structum therapy of patients with rheumatoid arthritis].
    Shmidt EI; Belozerova IV; Akhmedzhanov FM; Soldatov DG
    Ter Arkh; 2004; 76(11):93-5. PubMed ID: 15658549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of chondroitin sulphate in the treatment of elderly patients with gonarthrosis and coxarthrosis].
    Lazebnik LB; Drozdov VN
    Ter Arkh; 2005; 77(8):64-9. PubMed ID: 16206609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structum (chondroitin sulfate)--a new agent for the treatment of osteoarthrosis].
    Alekseeva LI; Benevolenskaia LI; Nasonov EL; Chichasova NV; Kariakin AN
    Ter Arkh; 1999; 71(5):51-3. PubMed ID: 10399232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of clinical response to intraarticular Hylan injections -- a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging.
    Anandacoomarasamy A; Bagga H; Ding C; Burkhardt D; Sambrook PN; March LM
    J Rheumatol; 2008 Apr; 35(4):685-90. PubMed ID: 18278831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level.
    Jones EA; Crawford A; English A; Henshaw K; Mundy J; Corscadden D; Chapman T; Emery P; Hatton P; McGonagle D
    Arthritis Rheum; 2008 Jun; 58(6):1731-40. PubMed ID: 18512779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial fluid recruits human mesenchymal progenitors from subchondral spongious bone marrow.
    Endres M; Neumann K; Häupl T; Erggelet C; Ringe J; Sittinger M; Kaps C
    J Orthop Res; 2007 Oct; 25(10):1299-307. PubMed ID: 17549723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis.
    Honsawek S; Tanavalee A; Sakdinakiattikoon M; Chayanupatkul M; Yuktanandana P
    Clin Biochem; 2009 Jun; 42(9):808-12. PubMed ID: 19217889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degeneration of normal articular cartilage induced by late phase osteoarthritic synovial fluid in beagle dogs.
    Xu QR; Dong YH; Chen SL; Bao CD; Du H
    Tissue Cell; 2009 Feb; 41(1):13-22. PubMed ID: 18692211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities of cartilage lesions due to intra-articular changes of the pH-milieu].
    Weller S
    Hefte Unfallheilkd; 1976; (128):98-109. PubMed ID: 10265
    [No Abstract]   [Full Text] [Related]  

  • 17. Chondroitin sulfate for the treatment of hip and knee osteoarthritis: current status and future trends.
    Kubo M; Ando K; Mimura T; Matsusue Y; Mori K
    Life Sci; 2009 Sep; 85(13-14):477-83. PubMed ID: 19695267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural characteristics of synovial effusion cells in some arthropathies.
    Kapitonova MY; Othman M
    Malays J Pathol; 2004 Dec; 26(2):73-87. PubMed ID: 16329559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Hsiao TY; Lu KH
    J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1H and 51V NMR investigations of the molecular nature of implant-derived vanadium ions in osteoarthritic knee-joint synovial fluid.
    Silwood CJ; Grootveld M
    Clin Chim Acta; 2007 May; 380(1-2):89-99. PubMed ID: 17346687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.